Il Dong Pharmaceutical Co Ltd (249420) — Cash Flow Reinvestment Rate
Il Dong Pharmaceutical Co Ltd (249420) has a Cash Flow Reinvestment Rate of 0.65x as of September 2025, reinvesting ₩7.32 Billion (capex ₩5.97 Billion plus investments ₩-1.35 Billion) from operating cash flow of ₩11.28 Billion. Explore 249420 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Il Dong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Il Dong Pharmaceutical Co Ltd across 6 annual periods. Also explore 249420 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Il Dong Pharmaceutical Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Il Dong Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 249420 company net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.95x | ₩26.81 Billion | ₩28.29 Billion | ₩14.05 Billion | ▲ +10.6% |
| 2020 | 0.86x | ₩16.59 Billion | ₩19.37 Billion | ₩14.35 Billion | ▲ +138.1% |
| 2019 | 0.36x | ₩14.89 Billion | ₩41.37 Billion | ₩12.06 Billion | ▲ +42.4% |
| 2018 | 0.25x | ₩16.85 Billion | ₩66.65 Billion | ₩15.09 Billion | ▼ -32.8% |
| 2017 | 0.38x | ₩27.71 Billion | ₩73.72 Billion | ₩16.73 Billion | ▼ -38.3% |
| 2016 | 0.61x | ₩28.01 Billion | ₩45.98 Billion | ₩14.22 Billion | — |